😎 Summer Sale Exclusive - Up to 50% off AI-powered stock picks by InvestingProCLAIM SALE

Biogen Inc (BIIB)

NASDAQ
Currency in USD
Disclaimer
232.50
+6.47(+2.86%)
Real-time Data

BIIB Comments

BIIN will go to $220 after earnings!
You were right .👍
God pless💖🙏
I Like read this👍👍
biogien stock can beat life high next 100% return expect gene therapy big booster
comming soon??
I Hope Eli Lilly Will fail full approval from FDA with only 1 valid study (phase 3) and higher risque of aria than Biogen .
will start to go up next weeks, big time
hummm ok so the rumors was alrady bought lol back to 200
As we see you were right
I wait since 9h30 no news FDA most wait the close before their verdict why they play like that??
Why monday the FDA news comming today.
easy trade just buy and wait friday and sell monday.........
????????
so FDA will approved... they approved Aducanumab against non expert approval, so why share is so flat
Expert adviser vote for full approval
Good news medicare will pay if full approuval from FDA😉
Is that the fda can full approve lly donanemab with only 1 study??? The phase 2 has been refused due to less than 100 people after 1 year i hope no the rules are same for every one.
Another good news result from phase 1b study indicates the reduction of tau proteins linked to alzheimer's.Coming april 25 als probable approval july 6 lecanemab probable full approval August 5 zuralonone probable approval everything in place for a very strong increase or potential take over.🤑🤑
Next target for july 6 after FDA full approuval lequembi 400$ 500$???
minimum 500
If RETA rise to 175% after FDA approuval for rare genetic disorder drug with negative quarterly, why Biogen can do same with lecanemab potentially approved us japan europe china with zuranolone for mdd and postpartum to come this year (august)???? Why not??
not impossible but approvals of both zuranolone and lecanemab will likely drive the stock up in the band 90-110%
excellent earnings better than tsla and going down!!!
What happened to eisai.co?
I Hope you are right it makes all the difference if they pay!
Medicare don't want to pay😬😬
false.
there is no reason it doesnt get the approval from FDA, Lecanemab has better result thant Aducanumab
300
What will happen next friday 01-06-2023 if Fda approve lecanemab your price target???
in 1 month 500
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.